financetom
Business
financetom
/
Business
/
Ryder System's Q1 Comparable Earnings Fall, Revenue Rises; Q2 EPS Outlook Issued, 2024 Guidance Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ryder System's Q1 Comparable Earnings Fall, Revenue Rises; Q2 EPS Outlook Issued, 2024 Guidance Updated
Apr 23, 2024 5:49 AM

08:16 AM EDT, 04/23/2024 (MT Newswires) -- Ryder System (R) reported Q1 comparable earnings from continuing operations, a non-GAAP measure, Tuesday of $2.14 per diluted share, down from $2.81 a year earlier.

Analysts polled by Capital IQ expected $1.71.

Revenue for the quarter ended March 31 was $3.10 billion, up from $2.95 billion a year earlier.

Four analysts surveyed by Capital IQ expected $3.06 billion.

Ryder said it expects Q2 comparable EPS of $2.75 to $2.95. Analysts polled by Capital IQ expect $2.79.

The company now expects fiscal 2024 comparable EPS of $11.75 to $12.50, compared with earlier guidance of between $11.50 and $12.50. Analysts surveyed by Capital IQ expect $11.70. The company lowered its estimate for 2024 revenue growth to about 10% from its prior outlook of 13%.

Shares of the company were up 1.8% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alaska Airlines, Hawaiian Airlines extend review period of deal amid antitrust scrutiny
Alaska Airlines, Hawaiian Airlines extend review period of deal amid antitrust scrutiny
Jul 30, 2024
July 30 (Reuters) - Alaska Air Group ( ALK ) has agreed to extend the review period for the proposed $1.9 billion acquisition of rival Hawaiian Airlines amid antitrust scrutiny from the U.S. Department of Justice, the carrier said in a filing on Tuesday. Our airlines have mutually agreed with the DOJ on a brief extension of the formal review...
Merck second quarter tops Street view on strong Keytruda sales
Merck second quarter tops Street view on strong Keytruda sales
Jul 30, 2024
July 30 (Reuters) - Merck & Co ( MRK ) posted higher-than-expected second-quarter results on Tuesday on strong growth of its blockbuster cancer immunotherapy Keytruda, the world's best-selling prescription medicine. New Jersey-based Merck ( MRK ) slightly raised its full-year sales projections, following other big pharmaceutical companies like Roche, Johnson & Johnson and Bristol Myers Squibb, which lifted their forecasts...
Procter & Gamble misses sales expectations on slowing demand
Procter & Gamble misses sales expectations on slowing demand
Jul 30, 2024
(Reuters) -Procter & Gamble missed Wall Street expectations for fourth-quarter sales on Tuesday, on weak demand for its skincare products in major market China and waning price benefitsin the U.S. and Europe for its home care products. Shares of the Tide detergent maker fell 2.3% in premarket trading. P&G has scaled back on further price hikes and instead have been...
Pfizer raises annual profit forecast after better-than-expected COVID sales
Pfizer raises annual profit forecast after better-than-expected COVID sales
Jul 30, 2024
July 30 (Reuters) - U.S. drugmaker Pfizer ( PFE ) on Tuesday raised its annual profit forecast after reporting better-than-expected sales of its COVID vaccine and antiviral treatment. New Jersey-based Pfizer ( PFE ) now expects annual profit to be in the range of $2.45 to $2.65 per share, compared with its prior profit forecast of $2.15 to $2.35 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved